Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
For Align, the big-picture thesis still hinges on its leadership in clear aligners, the stickiness of its digital orthodontic ecosystem and the willingness of dentists, orthodontists and patients to keep adopting its technology. The latest quarter reinforces that story: record Invisalign volumes, improving margins and a 2026 outlook for low single digit revenue growth show a business that is growing, but at a measured pace, even after a strong share price rebound in recent months. Short term, the key catalyst is whether that volume momentum, especially via dental service organizations and international markets, can offset Align’s premium valuation and relatively modest growth guidance. At the same time, new initiatives like iTero Lumina and the Swiss Oral Health Study highlight management’s push to deepen clinical credibility, which may help, but do not remove the competitive and pricing risks the stock still faces.
However, one risk in particular could matter more than many investors might expect. Align Technology's shares have been on the rise but are still potentially undervalued by 16%. Find out what it's worth.Seven fair value estimates from the Simply Wall St Community span roughly US$140 to just over US$223 per share, underscoring how differently people are sizing up Align’s upside after the recent earnings beat and buybacks. With growth guidance now set in the low single digits, it is worth weighing these contrasting views alongside the risk that premium pricing and slower top line expansion could keep sentiment sensitive to even small operational missteps.
Explore 7 other fair value estimates on Align Technology - why the stock might be worth 25% less than the current price!
Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com